World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

@article{Bandelow2008WorldFO,
  title={World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision},
  author={Borwin Bandelow and Joseph Zohar and Eric Hollander and Siegfried Kasper and Hans-J{\"u}rgen M{\"o}ller and WFSBP TASK FORCE ON TREATMENT GUIDELINES FOR ANXIE},
  journal={The World Journal of Biological Psychiatry},
  year={2008},
  volume={9},
  pages={248 - 312}
}
  • B. Bandelow, J. Zohar, WFSBP TASK FORCE ON TREATMENT GUIDELINES FOR ANXIE
  • Published 1 October 2002
  • Psychology, Medicine
  • The World Journal of Biological Psychiatry
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the pharmacological treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now… 
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD.
  • B. Bandelow, C. Allgulander, J. Zohar
  • Psychology, Medicine
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2022
TLDR
Recommendations for the treatment of OCD and PTSD can be effectively treated with CBT and medications, and CBT is the psychotherapy modality with the best body of evidence.
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders.
  • B. Bandelow, C. Allgulander, J. Zohar
  • Psychology, Medicine
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2022
TLDR
Recommendations for the treatment of panic disorder/agoraphobia (PDA), generalised anxiety disorder (GAD), social anxiety Disorder (SAD), specific phobias, mixed anxiety disorders in children and adolescents, separation anxiety and selective mutism are provided.
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015
TLDR
This second part of the WFSBP guidelines on depressive disorders covers the management of the maintenance phase treatment, and is primarily concerned with the biological treatment of adults and also, albeit to a lesser extent, children, adolescents and older adults.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence
TLDR
Evidence is provided for the efficacy of a number of medications to treat opioid abuse and dependence, particularly the opioid agonists methadone or buprenorphine, which have great relevance for clinical practice.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression
  • H. Grunze, E. Vieta, S. Kasper
  • Medicine, Psychology
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2010
TLDR
Ten pharmacological monotherapies or combination treatments with at least limited positive evidence for efficacy in bipolar depression are identified, several of them still experimental and backed up only by a single study.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder
  • H. Grunze, E. Vieta, S. Kasper
  • Medicine, Psychology
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2013
TLDR
The purpose is to supply a systematic overview of all scientific evidence pertaining to the long-term treatment of bipolar disorder in adults, and lithium continues to be the substance with the broadest base of evidence across treatment scenarios.
Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care
TLDR
A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy and may improve treatment of anxiety disorders, OCD, and PTSD in primary care.
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation
  • A. Hasan, P. Falkai, H. Möller
  • Psychology, Medicine
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2015
TLDR
This third part of the updated guidelines covers the management of the following specific treatment circumstances: comorbid depression, suicidality, variousComorbid substance use disorders (legal and illegal drugs), and pregnancy and lactation.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder
  • H. Grunze, E. Vieta, S. Kasper
  • Psychology, Medicine
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2018
TLDR
Current treatment recommendations are still based on limited evidence, and there is a clear demand for confirmative studies adopting the DSM-5 specifier with mixed features concept.
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
  • A. Hasan, P. Falkai, H. Möller
  • Medicine, Psychology
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2013
TLDR
These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry guidelines for biological treatment of schizophrenia published in 2006 and provide evidence-based practice recommendations that are clinically and scientifically meaningful.
...
...

References

SHOWING 1-10 OF 1,058 REFERENCES
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders
  • B. Bandelow, J. Zohar, E. Hollander, S. Kasper, H. Möller, WFSBP Task Force on Treatment Guidelines for Anxie
  • Psychology, Medicine
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2002
TLDR
Recommendations for the pharmacological treatment of anxiety and obsessive-compulsive disorders are presented, based on available randomized, placebo- or comparator-controlled clinical studies, and SSRIs are recommended for the first line and MAOIs, moclobemide and benzodiazepines as second line.
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.
TLDR
These guide lines for the biological treatment of schizophrenia were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry to reach a consensus on a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence.
Practice guideline for the treatment of patients with obsessive-compulsive disorder.
TLDR
The guideline remains substantially correct and current in its recommendations, and some recommendations are now supported by stronger evidence, and more data is available regarding rates of response to some interventions.
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
TLDR
Results of these post hoc analyses show that comorbid illness adversely impacted response to pharmacotherapy with paroxetine in pediatric OCD and significantly increased risk of relapse following withdrawal from treatment.
Current treatments of the anxiety disorders in adults
Efficacy of Drug Treatment in Obsessive–Compulsive Disorder: a Meta-Analytic Review
TLDR
Antidepressant drugs are effective in the short-term treatment of patients suffering from OCD; although the increase in improvement rate over placebo was greater for clomipramine than for SSRIs, direct comparison between these drugs showed that they had similar therapeutic efficacy on obsessive–compulsive symptoms.
International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992–1997
TLDR
This report focuses on the experts' responses to questions about therapeutic options relevant to seven vignettes describing typical cases of different anxiety disorders, as well as on the preferred initial treatment strategy.
Obsessive-Compulsive Disorder: An Open-Label Pilot Trial of Escitalopram
TLDR
Despite the small sample size and the open-label nature of this trial, these data suggest that escitalopram may be a useful option for patients with OCD.
Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia.
TLDR
These guidelines state that drug treatment should be complemented by behaviour therapy and the presence of severe agoraphobia is a negative prognostic indicator, whereas comorbid depression, if properly treated, has no consistent effect on outcome.
An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.
TLDR
The study presented here summarizes a 12-week, open-label trial of paroxetine among patients with noncombat-related, chronic PTSD, finding highly significant improvement in all three symptom clusters, as well as in associated anxiety, depressive, and dissociative symptoms.
...
...